top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Malignant Mesothelioma
Malignant Mesothelioma
Autore L. Pouliquen Daniel
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (328 p.)
Soggetto topico Medicine
Soggetto non controllato asbestos
asbestos exposure
BAP1
biomarkers
cancer biomarkers
cancer-specific mutations
cancers
carbon nanotubes
carcinogenesis
CDKN2A
circulating tumor DNA
dendritic cells
DNA damage response
DNA methylation
DNA sequencing
drug repurposing
epigenome-wide analysis
epithelioid
extrapleural pneumonectomy
fatty acid-binding protein
FDG
first line
gene expression
genomics
Hippo pathway
histotype
immune therapy
immunogenicity
immunohistochemistry
immunotherapy
infiltrating immune cells
inflammation
interaction analysis
laminin subunit beta-2
liquid biopsies
lurbinectedin
lymphocyte-to-monocyte ratio
macrophage-capping protein
malignant mesothelioma
malignant pleural mesothelioma
mesothelioma
mesothelium
meta-analysis
metabolomics
MPM
MTAP
mutation
n/a
network analysis
NF2
oxidative stress
PET-CT
plasma
pleural effusion
pleural mesothelioma
pleurectomy decortication
predictive biomarker
prognostic biomarker
protein-protein interactions
proteomics
PTCH1
radiotherapy
redox-sensitive factors
sarcomatoid
selenium-binding protein 1
SETD2
survival
survival analysis
systematic review
systems biology
targeted therapy
therapy response
tumor microenvironment
tumor suppressor
tumor-associated macrophages
VATS
WDPM
well-differentiated papillary mesothelioma
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557359303321
L. Pouliquen Daniel  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Renal Cell Carcinoma
Renal Cell Carcinoma
Autore López José I
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (500 p.)
Soggetto topico Biology, life sciences
Soggetto non controllato 11) translocation renal cell carcinoma
ALK
AMP-activated protein kinases
anaplastic lymphoma kinase rearrangement
aurora A
biomarker
cancer immunotherapy
cancer-specific survival
CDKN1A expression
checkpoint inhibitors
chromophobe renal cell carcinoma
chromosomal loss
chronic kidney disease
circular RNAs in a clinico-genomic predictive model
clear cell renal cell carcinoma
clear cell Renal Cell Carcinoma
collecting duct carcinoma
copy number alteration
copy number analysis
copy number loss
curcumin
cytoreductive nephrectomy
diagnostic and prognostic markers
drug sensitivity
efficacy
emerging entity
EMT like
eosinophilic variant
ESC
everolimus
EVI1
experimental validation of circular RNA
FISH
FOXO3
gene expression
gene signature
genetic association
ghrelin
glutathione metabolism
glutathione transferase omega 1
glutathione transferase omega 2
glycomarkers
glycoproteomics
HOT
hyperosmolality
identification of circular RNAs
IL-1?
IL-2
IL13R?1
IL4R?
immune checkpoint inhibitors
immune infiltration
immunohistochemistry
immunotherapy
inflammation markers
integrins
intratumour heterogeneity
invasion
JAK2
kidney
kidney cancer
label-free
LOT
metabolic reprogramming
metabolome
metabolome profiling
metastasis
metastatic ccRCC
microRNA
miR-133b
miR-146a-5p
miR-155-5p
MiT family translocation renal cell carcinoma
MMP-9
MMP10
molecular genetic features
MTA2
mTOR
mTOR inhibitors
mutation
N-glycomapping
n/a
nephrectomy
new entity
NK cells
oncocytic renal tumor
overall survival
pale cell
Papillary renal cell carcinoma (pRCC)
patient survival
PBRM1
PD-L1
pentose phosphate pathway
PI3K/Akt/mTOR
polybromo-1
polymorphism
PPP
practical approach
predictive factors
predictive role
pro-IL-1?
prognosis
prognostic factors
programmed death-ligand 1
proliferation
proteome profiling
Raf/MEK/ERK
RCC
recurrence free survival
recurrence-free survival
renal cancer
renal cell
renal cell cancer
renal cell carcinoma
review
RNA sequencing
sarcomatoid
SMAD proteins
solute carrier proteins
statins
survival
survival prediction
t(6
targeted therapy
TCA cycle
TCGA
TFE3
TFEB
TFEB-amplified renal cell carcinoma
toxicity
transforming growth factor beta
tumor adhesion
tumor microenvironment
tumor migration
tumor slice culture
tyrosine kinase inhibitors
unclassified renal cell carcinoma
unclassified renal tumor
uric acid
urine
VEGF inhibitors
von Hippel-Lindau
Xp11 translocation renal cell carcinoma
ISBN 3-03928-639-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910404087003321
López José I  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui